Chronic Kidney Disease-Mineral and Bone Disorder, Vitamin D Deficiency, and Secondary Hyperparathyroidism
- 9 November 2019
- book chapter
- other
- Published by Springer Science and Business Media LLC
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing DialysisThe New England Journal of Medicine, 2012
- Update on fibroblast growth factor 23 in chronic kidney diseaseKidney International, 2012
- Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney DiseaseJAMA, 2012
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Phosphate binders for preventing and treating bone disease in chronic kidney disease patientsEmergencias, 2011
- FGF-23: More than a regulator of renal phosphate handling?Journal of Bone and Mineral Research, 2010
- Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled TrialsAmerican Journal of Kidney Diseases, 2009
- Oral phosphate bindersKidney International, 2009
- Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)American Journal of Kidney Diseases, 2009
- The Mechanism of Phosphorus as a Cardiovascular Risk Factor in CKDJournal of the American Society of Nephrology, 2008